Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the American Medical Directors Association|June 16, 2020
Health Outcomes of Immigrants in Nursing Homes: A Population-Based Retrospective Cohort Study in Ontario, CanadaAhwon Jeong, Julie Lapenskie, Robert Talarico, et al.
The Oncologist|June 6, 2019
Why "Reply All" Can Push All the Wrong ButtonsSharon McGee, Mark Clemons, Anil Abraham Joy, et al.
BMC Geriatrics|September 5, 2023
Identifying predictors of cognitive decline in long-term care: a scoping reviewGaurav Arora, Christina Milani, Peter Tanuseputro, et al.
Breast Cancer Research and Treatment|August 11, 2019
Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patientsAngel Arnaout, Susan Robertson, Gregory R Pond, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|March 25, 2022
Access to Long-Term Care for Minority Populations: A Systematic ReviewMary M Scott, Alain Mayhew, Ahwon Jeong, et al.
BMJ Open|July 11, 2020
Prospective randomised controlled trial using the REthinking Clinical Trials (REaCT) platform and National Surgical Quality Improvement Program (NSQIP) to compare no preparation versus preoperative oral antibiotics alone for surgical site infection rates in elective colon surgery: a protocolSameer S Apte, Husein Moloo, Ahwon Jeong, et al.
Annals of Surgical Oncology|September 7, 2018
Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer SurgeryLeonard Angka, Andre B Martel, Marisa Kilgour, et al.
Annals of Surgical Oncology|July 25, 2022
A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery PatientsLeonard Angka, Andre B Martel, Juliana Ng, et al.
Breast Cancer Research and Treatment|August 9, 2019
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patientsAngel Arnaout, Susan J Robertson, Gregory R Pond, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate CancerMegan M Tu, Mark Clemons, Carol Stober, et al.
Pageof 2